Where Ocean Biomedical Stands With Analysts Apr 27, 2023 benzinga Read More Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17 Apr 27, 2023 AlphaStreetNews Read More Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan Kurtis Apr 25, 2023 Yahoo Finance Read More Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference Apr 25, 2023 AlphaStreet Read More EXCLUSIVE: Ocean Biomedical's Co-Founder Jack Elias To Receive US Patent For Lung Fibrosis Therapeutics Apr 20, 2023 Yahoo Finance Read More Ocean Biomedical Inc. (OCEA) Has Great Growth Outlook For 2023 Apr 17, 2023 marketingsentinel Read More Ocean Biomedical Blasts Out of the Water on New Malaria Patent Apr 13, 2023 TipRanks Read More Why Is Ocean Biomedical (OCEA) Stock Up 50% Today? Apr 13, 2023 Investor Place Read More Ocean Biomedical's Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics Apr 13, 2023 Benzinga Read More Ocean Biomedical Commits to Using OCF203 as a Therapeutic for Fatal Pulmonary Fibrosis Caused by HermanskyPudlak Syndrome HPS Apr 06, 2023 Best Stocks Read More
Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17 Apr 27, 2023 AlphaStreetNews Read More
Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan Kurtis Apr 25, 2023 Yahoo Finance Read More
Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference Apr 25, 2023 AlphaStreet Read More
EXCLUSIVE: Ocean Biomedical's Co-Founder Jack Elias To Receive US Patent For Lung Fibrosis Therapeutics Apr 20, 2023 Yahoo Finance Read More
Ocean Biomedical Inc. (OCEA) Has Great Growth Outlook For 2023 Apr 17, 2023 marketingsentinel Read More
Ocean Biomedical's Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics Apr 13, 2023 Benzinga Read More
Ocean Biomedical Commits to Using OCF203 as a Therapeutic for Fatal Pulmonary Fibrosis Caused by HermanskyPudlak Syndrome HPS Apr 06, 2023 Best Stocks Read More
